Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI -- Ignore unavailable to you. Want to Upgrade?

To: Nick who wrote (4471)	8/25/1998 10:26:00 AM
From: Mama Bear	Read Replies (2) \| Respond to of 5736

Nick, I am always amazed at how shareholders in company's like this are concerned about things peripheral to the company, rather than worrying about the company. I notice that there is still no distribution deal as of today. CCSI is coming up on 13 months since FDA approval. Barb

To: Nick who wrote (4471)	8/25/1998 12:33:00 PM
From: Robin	Read Replies (2) \| Respond to of 5736

Nick, I would believe that Milberg-Weiss withdrew representation for the class-action once they had formally determined that the eventual payoff in the event of a successful litigation would be too small for a firm of their stature. They will continue to pursue bigger fish while allowing this litigation to trickle down to less prominent class-action legal firms. They are profit oriented and there is not enough money to be made through a litigation against CCSI. It's that simple! Keep in mind though, if some of the postings here are legitimate (and I believe many are), then the staff at CCSI was negligent in its obligation to the shareholders. There are too many postings of people here who have spoken with either Darby or Jennifer and gotten estimates of when the deal would be done, and one has to believe that this has happened on at least several occasions. This dissemination of information should have and could have been handled through periodic press releases, and should never have been disclosed through random phone conversations. This type of activity more often than not proves to be detrimental to stockholders of the company and generally leads to some sort of legal action or SEC penalty, more likely the latter. Personally, I believe that CCSI will avoid legal action by their stockholders only if the deal remains in negotiation and they are eventually forced into bankruptcy. Should CCSI finally do something concrete to generate revenues (get the deal done -LOL- or break into other applications for the product), then the legal firms are lined up in position to collect for themselves first and then their plaintiffs. As for those of you touting CCSI marketing, explain this from the YAHOO thread! messages.yahoo.com@m2.yahoo.com Apparently SPRX is out there getting publicity with the American public. While hobnobbing with the medical community is important, it is equally important to get brand recognition with the public! Does anyone remember BETA vs. VHS? Sony was pumping the professional community with the virtues of their technically superior product (BETA) while Matsushita (VHS) quietly provided the public what they wanted, a much larger selection of movie titles to go with the player. Who won that battle? The one that went after the American public. Rockin' Robin